Centre de recherche clinique Étienne-Le Bel du CHUS

At a Glance

The Research Center of the Centre hospitalier universitaire de Sherbrooke (CHUS; Sherbrooke university hospital center) enjoys a unique advantage in Québec:

  • its closeness to the hospital, the Faculty of Medicine and Health Sciences (FMSS) at the Université de Sherbrooke, and the Institut de pharmacologie de Sherbrooke (Institute of pharmacology of Sherbrooke)
  • its proximity to the FMSS's Pavillon de recherche appliquée sur le cancer (Applied cancer research pavilion) and biopharmaceutical firms, including the Charles River Laboratories preclinical research center.
The CRCHUS remains unique overall for its integrated approach in which fundamental, clinical, epidemiological, and evaluative research coalesce.

Because of its R&D expertise within its research axes, the CRCHUS stands out above other research centers on the provincial, national, and international levels.

CR-CHUS researchers have been combining their expertise since 1980. Our current and future successes reflect the passion and hard work of over 900 researchers, highly qualified research staff dedicated to clinical research, and graduate students. 

  • Microbiologie
  • Infirmière de recherche en endocrinologie
  • Mentorat auprès des jeunes | Martin Bisaillon, chercheur

The Centre hospitalier universitaire de Sherbrooke (CHUS; Sherbrooke university hospital center)

As Québec's fourth largest hospital center, the CHUS plays a triple role of local, regional, and supraregional hospital by also providing some types of certain tertiary care to the populations of Estrie as well as that of the Centre-du-Québec and Montérégie regions. Overall, the population served totals more than a million individuals, of which about a third come exclusively to the CHUS.


Main Partners

Collaboration with partners such as the Estrie Health and Social Services Agency; the Sherbrooke Health Expertise Centre; the Ministry of Health and Social Services; Sherbrooke Innopole; and the Université de Sherbrooke enables us to continue innovating and providing for regional synergy in scientific and technological development. We also benefit from the ongoing support of financial partners, including the Fondation du CHUS (foundation), the Fonds de recherche du Québec - Santé (FRQ-S; Québec health-research fund), and the Canadian Institutes of Health Research (CIHR).

To top